The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II

Genes and Development

Volumn 11, Issue 20, 1997, Pages 2645-2657

  Cujec, Thomas P ^a   Okamoto, Hiroshi ^a   Fujinaga, Koh ^a   Meyer, Jon ^a   Chamberlin, Holly ^a   Morgan, David O ^a   Peterlin, B Matija ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CAK; CDK7; CTD; HIV; Phosphorylation; Pol II; Transactivator Tat

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA TRANSLATION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030856701     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.20.2645     Document Type: Article

References (83)

1. Akhtar, A., G. Faye, and D.L. Bentley. 1996. Distinct activated and non-activated RNA polymerase II complexes in yeast. EMBO J. 15: 4654-4664.
2. Akoulitchev, S., T.P. Makela, R.A. Weinberg, and D. Reinberg. 1995. Requirement for TFIIH kinase activity in transcription by RNA polymerase II. Nature 377: 557-560.
3. Alonso, A., D. Derse, and B.M. Peterlin. 1992. Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells. J. Virol. 66: 4617-4621.
4. Blau, J., H. Xiao, S. McCracken, P. O'Hare, J. Greenblatt, and D. Bentley. 1996. Three functional classes of transcriptional activation domains. Mol. Cell. Biol. 16: 2044-2055.
5. Carroll, R., B.M. Peterlin, and D. Derse. 1992. Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans-activators. J. Virol. 66: 2000-2007.
6. Chao, D.M., E.L. Gadbois, P.J. Murray, S.F. Anderson, M.S. Sonu, J.D. Parvin, and R.A. Young. 1996. A mammalian SRB protein associated with an RNA polymerase II holoenzyme. Nature 380: 82-85.
7. Chiang, C.-M. and R.G. Roeder. 1995. Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Nature 267: 531-536.
8. Chun, R.F., and K.T. Jeang. 1996. Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1. J. Biol. Chem. 271: 27888-27894.
9. Cismowski, M.J., G.M. Laff, M.J. Solomon, and S.I. Reed. 1995. KIN28 encodes a C-terminal domain kinase that controls mRNA transcription in Saccharomyces cerevisiae but lacks cyclin-dependent kinase-activating kinase (CAK) activity. Mol. Cell. Biol. 15: 2983-2992.
10. Cujec, T.P., H. Cho, E. Maldonado, J. Meyer, D. Reinberg, and B.M. Peterlin. 1997. The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol. Cell. Biol. 17: 1817-1823.
11. Cullen, B.R. 1993. Does HIV-1 Tat induce a change in viral initiation rights? Cell 73: 417-420.
12. Dahmus, M.E. 1994. The role of multisite phosphorylation in the regulation of RNA polymerase II activity. Prog. Nucleic Acid Res. Mol. Biol. 48: 143-179.
13. _. 1995. Phosphorylation of the C-terminal domain of RNA polymerase II. Biochim. Biophys. Acta. 1261: 171-182.
14. _. 1996. Phosphorylation of mammalian RNA polymerase II. Methods Enzymol. 273: 185-193.
15. Desai, K., P.M. Loewenstein, and M. Green. 1991. Isolation of a cellular protein that binds to the human immunodeficiency virus Tat protein and can potentiate transactivation of the viral promoter. Proc. Natl. Acad. Sci. 88: 8875-8879.
16. Drapkin, R. and D. Reinberg. 1994. The multifunctional TFIIH complex and transcriptional control. Trends Biochem. Sci. 19: 504-508.
17. Drapkin, R., G. LeRoy, H. Cho, S. Akoulitchev, and D. Reinberg. 1996. Human cyclin-dependent kinase-activating kinase exists in three distinct complexes. Proc. Natl. Acad. Sci. 93: 6488-6493.
18. Feaver, W.J., O. Gileadi, Y. Li, and R.D. Komberg. 1991. CTD kinase associated with yeast RNA polymerase II initiation factor b. Cell 67: 1223-130.
19. Feaver, W.J., J.Q. Svejstrup, N.L. Henry, and R.D. Kornberg. 1994. Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell 79: 1103-1109.
20. Fisher, R.P. and D.O. Morgan. 1994. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78: 713-724.
21. Fisher, R.P., P. Jin, H.M. Chamberlin, and D.O. Morgan. 1995. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 83: 47-57.
22. Garcia-Martinez, L.F., G. Mavankal, J.M. Neveu, W.S. Lane, D. Ivanov, and R. B. Gaynor. 1997. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16: 2836-2850.
23. Gerber, H.P., M. Hagmann, K. Seipel, O. Georgiev, M.A. West, Y. Litingtung, W. Schaffner, and J.L. Corden. 1995. RNA polymerase II C-terminal domain required for enhancer-driven transcription. Nature 374: 660-662.
24. Hart, C.E., C.Y. Ou, J.C. Galphin, J. Moore, L.T. Bacheler, J.J. Wasmuth, S. Petteway Jr., and G. Schochetman. 1989. Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science 246: 488-491.
25. Herrmann, C.H., and A.P. Rice. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor. J. Virol. 69: 1612-1620.
26. Hodo III, H.G. and S.P. Blatti. 1977. Purification using polyethylenimine precipitation and low molecular weight subunit analyses of calf thymus and wheat germ DNA-dependent RNA polymerase II. Biochemistry 16: 2334-2343.
27. Hoeijmakers, J.H.J., J.-M. Egly, and W. Vermeulen. 1996. TFIIH: A key component in multiple DNA transactions. Curr. Opin. Genet. Dev. 6: 26-33.
28. Jeang, K.T., R. Chun, N.H. Lin, A. Gatignol, C.G. Glabe, and H. Fan. 1993. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J. Virol. 67: 6224-6233.
29. Jin, P., Y. Gu, and D.O. Morgan. 1996. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J. Cell Biol. 134: 963-970.
30. Jones, K.A. and B.M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63: 717-743.
31. Kao, S. Y., A.F. Calman, P.A. Luciw, and B.M. Peterlin. 1987. Anti-termination of transcription within the long terminal repeat of HIV-1 by Tat gene product. Nature 330: 489-493.
32. Kashanchi, F., G. Piras, M.F. Radonovich, J.F. Duvall, A. Fattaey, C.M. Chiang, R.G. Roeder, and J.N. Brady. 1994. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature 367: 295-299.
33. Kato, H., H. Sumimoto, P. Pognonec, C.H. Chen, C.A. Rosen, and R.G. Roeder. 1992. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes & Dev. 6: 655-666.
34. Keen, N.J., M.J. Gait, and J. Kam. 1996. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl. Acad. Sci. 93: 2505-2510.
35. Kerppola, T.K. and C.M. Kane. 1990. Analysis of the signals for transcription termination by purified RNA polymerase II. Biochemistry 29: 269-278.
36. Kim, K.-K., H.M. Chamberlin, D.O. Morgan, and S.-H. Kim. 1996. Three-dimensional structure of human cyclin H, a positive regulator of the CDK-activating kinase. Nature Struct. Biol. 3: 849-855.
37. Kim, Y.J., S. Bjorklund, Y. Li, M.H. Sayre, and R.D. Kornberg. 1994. A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. Cell 77: 599-608.
38. Kiadis, P., A. Sutton, and M. Solomon. 1996. The CDK-activating kinase (CAK) from budding yeast. Cell 86: 553-564.
39. Kuppuswamy, M., T. Subramanian, A. Srinivasan, and G. Chinnadurai. 1989. Multiple functional domains of Tat, the transactivator of HIV-1, defined by mutational analysis. Nucleic Acids Res. 17:3551-3561.
40. Laspia, M.F., A.P. Rice, and M.B. Mathews. 1989. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell 59: 283-292.
41. Laybourn, P.J., and M.E. Dahmus. 1989. Transcription-dependent structural changes in the C-terminal domain of mammalian RNA polymerase subunit IIa/o. J. Biol. Chem. 264: 6693-6698.
42. _. 1990. Phosphorylation of RNA polymerase IIa occurs subsequent to interaction with the promoter and before the initiation of transcription. J. Biol. Chem. 265: 13165-13173.
43. Liao, S.M., J. Zhang, D.A. Jeffery, A.J. Koleske, C.M. Thompson, D.M. Chao, M. Viljoen, H.J. van Vuuren, and R.A. Young. 1995. A kinase-cyclin pair in the RNA polymerase II holoenzymc. Nature 374: 193-196.
44. Lu, H., L. Zawel, L. Fischer, J.-M. Egly, and D. Reinberg. 1992. Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature 358: 641-645.
45. Lu, X., T.M. Welsh, and B.M. Peterlin. 1993. The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat. J. Virol. 67: 1752-1760.
46. Madore, S.J., and B.R. Cullen. 1995. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators. Virology 206: 1150-1154.
47. Madore, S.J. and B.R. Cullen. 1993. Genetic analysis of the co-factor requirement for human immunodeficiency virus type 1 Tat function. J. Virol. 67:3703-3711.
48. Makela, T.P., J.P. Tassan, E.A. Nigg, S. Frutiger, G.J. Hughes, and R.A. Weinberg. 1994. A cyclin associated with the CDK-activating kinase MO15. Nature 371: 254-257.
49. Maldonado, E. and D. Reinberg. 1995. News on initiation and elongation of transcription by RNA polymerase II. Curr. Opin. Cell Biol. 7:352-361.
50. Maldonado, E., R. Shiekhattar, M. Sheldon, H. Cho, R. Drapkin, J.A. Inostroza, P. Rickert, E. Lees, C.W. Anderson, S. Linn, and D. Reinberg. 1996. A human RNA polymerase II complex associated with SRB and DNA-repair proteins. Nature 381: 86-89.
51. Marciniak, R.A. and P.A. Sharp. 1991. HIV-1 Tat protein promotes formation of more processive elongation complexes. EMBO J. 10: 4189-4196.
52. Mavankal, G., S.H. Ou, H. Oliver, D. Sigman, and R.B. Gaynor. 1996. Human immunodeficiency virus type 1 and 2 proteins specifically interact with RNA polymerase II. Proc. Natl. Acad. Sci. 93: 2089-2094.
53. McCracken, S., N. Fong, K. Yankulov, S. Ballantyne, G. Pan, J. Greenblatt, S. D. Patterson, M. Wickens, and D.L. Bentley. 1997. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385: 357-361.
54. Nelbock, P., P.J. Dillon, A. Perkins, and C.A. Rosen. 1990. A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator. Science 248: 1650-1653.
55. O'Brien, T., S. Hardin, A. Greenleaf, and J.T. Lis. 1994. Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature 370: 75-77.
56. Okamoto, H., C.T. Sheline, J. Corden, K.A. Jones, and B.M. Peterlin. 1996. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc. Natl. Acad. Sci. 93: 11575-11579.
57. Ossipow, V., J.P. Tassan, E.A. Nigg, and U. Schibler. 1995. A mammalian RNA polymerase II holoenzyme containing all components required for promoter-specific transcription initiation. Cell 83: 137-146.
58. Parada, C.A. and R.G. Roeder. 1996. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature 384: 375-378.
59. Peterson, S.R., A. Dvir, C.W. Anderson, and W.S. Dynan. 1992. DNA binding provides a signal for phosphorylation of the RNA polymerase II heptapeptide repeats. Genes &. Dev. 6: 426-438.
60. Poteet-Smith, C.E., J.B. Shabb, S.H. Francis, and J.D. Corbin. 1997. Identification of critical determinants for autoinhibition in the pseudosubstrate region of type I alpha cAMP-dependent protein kinase. J. Biol. Chem. 272: 379-388.
61. Ratnasabapathy, R., M. Sheldon, L. Johal, and N. Hernandez. 1990. The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters. Genes & Dev. 4: 2061-2074.
62. Reardon, J.T., H. Ge, E. Gibbs, A. Sancar, J. Hurwitz, and Z.Q. Pan. 1996. Isolation and characterization of two human transcription factor IIH (TFIIH)-related complexes: ERCC2/CAK and TFIIH. Proc. Natl. Acad. Sci. 93: 6482-6487.
63. Rossignol, M., I. Kolb-Cheynel, and J.-M. Egly. 1997. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH. EMBO J. 16: 1628-1637.
64. Roy, R., J.P. Adamczewski, T. Seroz, W. Vermeulen, J.P. Tassan, L. Schaeffer, E.A. Nigg, J.H. Hoeijmakers, and J.M. Egly. 1994. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79: 1093-1101.
65. Selby, M.J., E.S. Bain, P.A. Luciw, and B.M. Peterlin. 1989. Structure, sequence, and position of the stem-loop in TAR determine transcriptional elongation by Tat through the HIV-1 long terminal repeat. Genes & Dev. 3: 547-558.
66. Serizawa, H., T.P. Makela, J.W. Conaway, R.C. Conaway, R.A. Weinberg, and R.A. Young. 1995. Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature 374: 280-282.
67. Sheldon, M., R. Ratnasabapathy, and N. Hernandez. 1993. Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs. Mol. Cell. Biol. 13: 1251-1263.
68. Shiekhattar, R., F. Mermelstein, R.P. Fisher, R. Drapkin, B. Dynlacht, H.C. Wessling, D.O. Morgan, and D. Reinberg. 1995. Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature 374: 283-287.
69. Steimle, V., L.A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75: 135-146.
70. Thompson, N.E., T.H. Steinberg, D.B. Aronson, and R.R. Burgess. 1989. Inhibition of in vivo and in vitro transcription by monoclonal antibodies prepared against wheat germ RNA polymerase II that react with the heptapeptide repeat of eukaryotic RNA polymerase II. J. Biol. Chem. 264: 11511-11520.
71. Thuret, J.-Y., J.-G. Valay, G. Faye, and C. Mann. 1996. Civ 1(CAK in vivo), a novel cdk-activating kinase. Cell 86: 565-576.
72. Tong-Starksen, S.E., P.A. Luciw, and B.M. Peterlin. 1987. Human immunodeficiency virus long terminal repeat responds to T cell activation signals. Proc. Natl. Acad. Sci. 84: 6845-6849.
73. Veschambre, P., P. Simard, and P. Jalinot. 1995. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo. J. Mol. Biol. 250: 169-180.
74. Wilson, C.J., D.M. Chao, A.N. Imbalzano, G.R. Schnitzler, R.E. Kingston, and R.A. Young. 1996. RNA polymerase II holoenzyme contains SWI/SNF regulators involved in chromatin remodeling. Cell 84: 235-244.
75. Wright, S., X. Lu, and B.M. Peterlin. 1994. Human immunodeficiency virus type 1 Tat directs transcription through attenuation sites within the mouse c-myc gene. J. Mol. Biol. 243: 568-573.
76. Wu-Baer, F., D. Sigman, and R.B. Gaynor. 1995. Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat. Proc. Natl. Acad. Sci. 92: 7153-7157.
77. Yang, X., C.H. Herrmann, and A.P. Rice. 1996. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J. Virol. 70: 4576-4584.
78. Yankulov, K.Y. and D.L. Bentley. 1997. Regulation of CDK7 substrate specificity by MAT1 and TFIIH. EMBO J. 16: 1638-1646.
79. Yankulov, K., K. Yamashita, R. Roy, J.-M. Egly, and D. Bentley. 1995. The transcriptional elongation inhibitor 5,6-dichlor-1-β-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J. Biol. Chem. 270: 23922-23925.
80. Yankulov, K.Y., M. Pandes, S. McCraken, D. Bouchard, and D. Bentley. 1996. TFIIH functions in regulating transcriptional elongation by RNA polymerase II in Xenopus oocytes. Mol. Cell. Biol. 16:3291-3299.
81. Yuryev, A., M. Patturajan, Y. Litingtung, R.V. Joshi, C. Gentile, M. Gebara, and J.L. Corden. 1996. The C-terminal domain of the largest subunit of RNA polymerase II interacts with a novel set of serine/arginine-rich proteins. Proc. Natl. Acad. Sci. 93: 6975-6980.
82. Zawel, L., K.P. Kumar, and D. Reinberg. 1995. Recycling of the general transcription factors during RNA polymerase II transcription. Genes & Dev. 9: 1479-1490.
83. Zhou, Q. and P.A. Sharp. 1996. Tat-SF1: Cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science 274: 605-610.